Antimalarial drugs - what is in use and what is in the pipeline.
about
Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stagesAnalogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivoDiscovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reducesMarine peptides and their anti-infective activitiesControl of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements.Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.Expanding the Antimalarial Drug Arsenal-Now, But How?High-throughput tri-colour flow cytometry technique to assess Plasmodium falciparum parasitaemia in bioassays.Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.Bioaffinity Mass Spectrometry Screening.Antitubercular pharmacodynamics of phenothiazinesAntimalarial drug resistance: a review of the biology and strategies to delay emergence and spreadPlasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.Antimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratus.Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.CD8(+) T Cell Responses to Plasmodium and Intracellular Parasites.Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy.Acridine and acridinones: old and new structures with antimalarial activity.Artemisinin derivatives: a patent review (2006 - present).Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.Understanding the DNA damage response in order to achieve desired gene editing outcomes in mosquitoes.Analytics of Quinine and its Derivatives.Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action.Hemozoin detection may provide an inexpensive, sensitive, 1-minute malaria test that could revolutionize malaria screening.Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes.Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties.Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii.Synthesis and biological evaluation of some pyrazole derivatives as anti-malarial agents.Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors.Multi-targeted activity of maslinic acid as an antimalarial natural compound.A concise total synthesis of (+/-)-anthecularin.Synthesis of novel benzimidazole acrylonitriles for inhibition of Plasmodium falciparum growth by dual target inhibition.Antimalarial Activity of Plant Metabolites.
P2860
Q21034076-8BC95A35-FD84-4254-A0B5-7A36258C09A0Q27861933-99D4ED0E-82EC-4D9A-8449-647D6158E896Q28271436-97E2765A-52BE-48AF-9B47-9F07619B7D2AQ28651520-ED585EDA-B211-47FF-9902-7272DAF2034EQ30565638-9E607BDB-DF37-4C79-A8C7-EE9FE2DD38CEQ33868254-72759736-7D01-447F-A5ED-AC96EBCDBB7CQ33916111-BABC9827-0640-4D96-8B9F-97FC1996CF3BQ34423023-BACD252B-87DC-465E-8565-D95B87633454Q35023695-F06A00E0-33A6-475B-984C-045B747CC264Q35136121-58CC0A7A-A877-44D6-A9C8-052F5D0FE5A0Q35895700-FAF46B5C-BF46-43B6-9338-0D333AD9DB57Q36675149-76DDC377-68D8-44CB-B8A8-A4778A275367Q36722524-CF9D6731-82F0-47EE-BAA9-C1A4676CAE12Q37215608-4B88DDF4-B674-412F-97A2-FEA4D2212DFEQ37253845-63BE5CFD-6C77-49C4-9D5E-C0CD57FE074EQ37278622-6F915155-1441-4C39-B6C2-174DE47C300DQ37372616-F1202B46-7A4C-4400-91DB-E13436B9A61BQ37626063-50323547-1CC1-4793-9C9C-92ED7387162BQ37698282-B4AABCC9-E312-4A89-A765-060D4A5B81C1Q37735182-27C65B79-C737-492A-A02C-80D4B0DA9721Q37889659-D354599E-D6E8-4018-B36E-9B6BD5E141C9Q38042732-AFB7306D-C8E3-4AE5-889C-A6E0E4C81BD0Q38245842-39782284-4E8D-41F5-AA72-10CF790C0513Q38321939-70678B1E-F5D7-4B87-8096-D7E07D53C38FQ38399873-4FD7B197-B99B-49D3-8EB8-D9B0C6206A05Q38915797-1FB11CC9-04FA-432A-825E-47549F626952Q39033669-055114D1-5F2D-4C7D-A21D-46BCB7D05551Q41757555-1664DC0F-CA61-48B6-9E93-FBB8D9F9EFB8Q41915835-CE11C5E0-DA8B-44FB-9926-07119E3BDC69Q41927043-9979759E-23BA-462C-AC03-AF7030A66347Q41931529-B1425220-607F-4158-A03B-7636936C031BQ42717133-B87639DD-606F-497A-B786-07FCBFC1CD8DQ42732002-CCD6F359-ABA8-4151-B066-B53FC49332EBQ46132920-95EF679B-3D9E-4A46-A83E-33BD96DABE1AQ46273729-1EF29EAA-4A5F-49B1-8A0A-A68AC7B1D130Q55113560-CC77EF66-FBB3-45E3-A6F1-2C588F7CA010
P2860
Antimalarial drugs - what is in use and what is in the pipeline.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimalarial drugs - what is in use and what is in the pipeline.
@en
Antimalarial drugs - what is in use and what is in the pipeline.
@nl
type
label
Antimalarial drugs - what is in use and what is in the pipeline.
@en
Antimalarial drugs - what is in use and what is in the pipeline.
@nl
prefLabel
Antimalarial drugs - what is in use and what is in the pipeline.
@en
Antimalarial drugs - what is in use and what is in the pipeline.
@nl
P2860
P356
P1476
Antimalarial drugs - what is in use and what is in the pipeline.
@en
P2093
Martin Schlitzer
P2860
P304
P356
10.1002/ARDP.200700184
P577
2008-03-01T00:00:00Z